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Abstract 
Objectives 
The 2015 EAHP Statement Survey was related to Sections 2, 5 and 6 of the European 
Statements of Hospital Pharmacy. In addition to the collection of statistical data about the 
level of implementation of the Statements, it was also intended to identify important 
barriers to their implementation. 
Methods 
The online questionnaire was sent to all hospital pharmacies in EAHP member countries. 
Data were analysed by researchers from Keele University School of Pharmacy, UK and the 
EAHP Survey Group. 
Results 
There were a total of 949 responses (response rate of 18 %). In the first part of the Survey, 
the authors collected data about the hospital pharmacy setting. While almost half of hospital 
pharmacies served over 500 beds, 80% of hospital pharmacies had 10 or less pharmacists. In 
section B, the authors gathered evidence about the degree of implementation of Sections 2, 
5 and 6 of the European Statements and the main barriers to and drivers of implementation. 
Five questions with the lowest implementation level were then further analysed.  
 
Only five countries had 50% or more of hospital pharmacies reporting that the hospital 
pharmacists routinely publish hospital pharmacy practice research. 67 % of participants 
stated that they had contingency plans for medicines shortages. The majority of countries 
(20) have less than half of respondents using computerised decision support to reduce the 
risk of medication errors. When asked if an audit had been undertaken in the last three 
years to identify priorities in medicines use processes, the mean percentage of positive 
responses for a country was 58%.  
Conclusions 
EAHP has gained an informative overview of the implementation level as well as the barriers 
to and drivers of implementation in Sections 2, 5 and 6. This is essential to inform the plans 
for EAHP to best support their implementation. 
 
What is already known on this subject 
The 2014/15 EAHP Baseline survey, as the first survey of new EAHP line, brought general 
knowledge about baseline level of Statements implementation in all six sections of European 
Statements. 
What this paper adds 
This paper deepens knowledge about the level of implementation in Statements section 2, 5 
and 6 together with identification of the main barriers to and drivers of implementation. 
The most challenging Statements for implementation in hospital pharmacies are: 
• the publication of the research activities,  
• creating contingency plans for medicines shortages,  
• implementing and using computer-supported decision tools,  
• involvement in developing local and national guidelines and policies,  
• identification priorities for improvement in medicines use processes. 
The most important barrier in implementation is insufficient capacity and different priorities 
of hospital and health-system managers. 
 
Introduction 
European Association of Hospital Pharmacists (EAHP) decided to change its survey model in 
2014, based on the proceedings of European Summit of Hospital Pharmacy which was held 
that year.[1] The delegates of the 2014 EAHP General Assembly discussed a transformation 
of the existing EAHP survey to modernise the approach by using an online tool to optimise 
data collection while minimising workload for survey respondents. This tool was intended to 
support EAHP efforts in implementation of the Summit outcomes – The European 
Statements of Hospital Pharmacy (Statements) and other EAHP’s major projects.[2] 
The EAHP Survey group therefore established a model with a ‘baseline survey’ and two 
‘statements surveys, rotating in 2-year cycles, each year covering 3 of 6 Section of EAHP 
Statements. This article brings an overview of most important results of the first ‘statements 
survey’ that covered Statements section 2, 5 and 6.  
Methods 
The survey was drafted following a meeting of the EAHP Survey Group and then conducted 
from October 2015 to December 2015, spanning 33 (of 34) EAHP member countries. 
 
The survey consisted of three sections: 
 
Section A:  general questions about the participant’s hospital pharmacy, such as workforce 
skill-mix and number of beds served 
Section B: questions about the current activity of pharmacists around each statement in 
Sections 2, 5 and 6 
Section C: questions about the hospital’s readiness and ability to implement the statements 
 
The questions in section A were designed to allow further analysis of dependencies between 
main implementation barriers and hospital type, level of staffing etc. 
 
The questions in Section B of the survey were divided into three categories. The first was to 
identify if the participant thought that the Statements were already being implemented 
within their hospital. To achieve this aim, the pharmacists who participated in the survey 
were asked to rate the degree to which they were able to comply with each statement. A 
value was allocated to each response using a scale of 1-5, where a 1 indicated that they were 
never able to comply with the statement, while a 5 indicated that they always complied with 
the statement. In section C, they were asked to what degree they agreed with the question 
and the same Likert scale was used (1 for strongly disagree, 5 for strongly agree).  
For the purposes of identifying those statements where the barriers to implementation were 
greatest, a response of 3, 4 or 5 was deemed to indicate less difficulty in complying with that 
statement – a ‘positive response’. A response of 1 or 2 was deemed to indicate some 
difficulty in complying with that statement - a ‘negative response’. Where this was the case, 
the participant was asked a follow up question to identify the barriers in implementing the 
statement.  
 
In the 2014/15 EAHP Statements survey, the respondent was prompted to give a free text 
answer to these follow up questions. This meant that analysing the results was very time 
consuming, especially when language translation of the text was needed. For this survey, a 
range of pre-selected options to assist in identifying barriers to implementation were given. 
Five standard pre-selected options were used for every question, with some questions 
having additional specific options. The five main options were: 
1. We are prevented by national policy and/or legislation 
2. Not considered to be a priority by my managers 
3. Not considered to be a priority by me 
4. We would like to do this but we have limited capacity 
5. We would like to do this but we have limited capability 
 
There was also an 'other' option field, where the respondent could still give a free-text 
response if they had a unique answer to give. Respondents were given the ability to select 
multiple options. 
 
Having identified the level of implementation of the statements, and any barriers to 
implementation, participants were also asked for specific information to deepen the 
understanding of the topic. For example, in addition to asking a participant if medication 
errors are reported in their hospital, and then, if not, why not, they are also asked how many 
medication errors were reported in the last year and what have they done with the results 
of any medication error reports.  
 
SurveyMonkey™ was used as the software tool for the survey. The EAHP Survey Group 
decided to use English as the only language for the Survey to facilitate data assessment and 
to avoid additional costs and possible mistakes hidden in the translations of questions and 
answers. The survey was conducted from October 2015 to mid-November 2015. National 
coordinators were involved in tracking of response rates in their country. In some countries, 
the national coordinators were also responsible for the dissemination of survey links. When 
the survey closed, there were a total of 952 responses, the results of which were exported 
from SurveyMonkey™ for further analysis and reporting. 
 
Results 
Response rates 
The response rates for completed surveys are listed in the table 1, broken down by country. 
The response rates from the 2014/15 Baseline survey [3] are given in the final column for 
comparison. The minimal difference on the overall response rate indicates that using an 
English version only appeared to have no significant impact on response rate. It might affect 
the numbers of responses in respective countries, but this will need to be confirmed by 
further investigation in future surveys. 
 
 Country Responses Requests Percentage Percentage (last year) 
Denmark 8 8 100% 88% 
Iceland 1 1 100% 100% 
Malta 4 6 67% 67% 
Austria 29 46 63% 49% 
Sweden 23 37 62% 47% 
Ireland 41 70 59% 53% 
Croatia 20 39 51% 82% 
Serbia 32 63 51% 63% 
Czech Republic 49 95 52% 61% 
Portugal 40 89 45% 20% 
Bosnia 9 21 43% 48% 
Slovenia 12 28 43% 68% 
Greece 44 108 41% 30% 
Romania 26 65 40% 44% 
Norway 12 33 36% 66% 
FYROM 11 31 36% 58% 
Germany 137 388 35% 25% 
Switzerland 21 60 35% 48% 
Luxembourg 2 6 33% 50% 
Estonia 7 22 32% 46% 
Hungary 32 103 31% 64% 
Lithuania 12 39 31% 13% 
Belgium 45 166 27% 25% 
Finland 22 82 27% 27% 
Bulgaria 17 68 25% 17% 
Netherlands 19 80 24% 35% 
UK 38 183 21% 38% 
Spain 41 250 16% 18% 
Slovakia 13 83 16% 48% 
Italy 55 606 9% 6% 
Turkey 25 509 5% 9% 
Latvia 2 43 5% 13% 
France 100 1888 5% 8% 
Total 949 5,316 18% 18% 
 
Table 1: Response rate per participating countries 
Section A 
Results found that 43% of the responders work in teaching hospitals (Fig 1). These numbers 
are almost the same as was seen in the Baseline survey (42%),[4] therefore the sample can 
be considered very similar in this survey from this point of view. 
 
The respondents indicated, that 71% of them were from general hospitals (Fig 2). From 
"other hospitals" category (n=275), 45 responses were from psychiatric hospitals, 13 from 
paediatric hospitals, 12 from traumatology hospitals, 24 from oncology and 22 from geriatric 
hospitals respectively. 
 
45% of hospital pharmacies served to 100-500 beds, 24% to 500-1000 beds, 22% to hospitals 
with more than 1000 beds, while 9% to less than 100 beds hospitals (Fig 3). 
 
While almost half of hospital pharmacies in the sample served more than 500 beds, the 
staffing numbers showed that 80% (n=712) of hospital pharmacies had 10 or less 
pharmacists (Figure 4). 
 
The situation was very similar with the number of pharmacy technicians as 72% of hospitals 
in the sample employed 1-10 full time equivalents of pharmacy technicians (n=642). 
Section B: Questions related to EAHP Statements Sections 2, 5, 6 
[Table 2] shows all of the questions asked in the survey regarding Sections 2, 5 and 6 of the 
Statements, and where applicable, the overall percentage of participants who gave a 
‘positive response’ to the question. When a participant gave a ‘negative response’ to a 
question, there was usually a follow up question of ‘What is preventing this?’.  
 
Questions where less than 75% of participants gave a positive response have been 
highlighted in red in the table, and questions where more than 90% of participants gave a 
positive response have been highlighted in green. The question numbering indicates the 
relationship between the questions and respective Statements: S21 is related to Statement 1 
in Section 2 and accordingly. 
EAHP Survey Questions 
Section 2: Selection, Procurement and Distribution 
S21 O u r  hospital has clear processes in place around the procurement of medicines. (94% of all responses were 
positive.) 
S212 W e r e  hospital pharmacists involved in the development of these? (93% of all responses were positive.) 
S214  Which processes were pharmacists involved in? 
S22  The pharmacists in our hospital take the lead in developing, monitoring, reviewing and improving 
medicine use processes and the use of medicine related technologies. (82% of all responses were 
 S23  Do you have a formulary in place in your hospital (79% of all responses were positive.) 
S232  The pharmacists in our hospital coordinate the development, maintenance and use of our formulary. 
(92% of all responses were positive.) 
S234 How would you categorise the level of influence your pharmacists have over the formulary? 
S235 What kinds of evidence do you use for development and maintenance of the formulary? 
S24 Procurement of non-formulary medicines in our hospital is done to a robust process. (85% of all 
responses were positive.) 
S242 Has a written complaint ever been made to your hospital about a patient missing a dose of a critical 
medicine? (72% of all responses were positive.) 
S25  The pharmacy in our hospital has contingency plans for medicines shortages. (67% of all responses were 
positive.) 
S252  Have you had reason to contact the medicines authority in your country because of medicines shortages? 
(60% of all responses were positive.) 
S2.5.3 What was the reason(s) for contacting the medicines authority due to medicines shortage? 
S26  The pharmacy in our hospital takes responsibility for all medicines logistics, including for investigational 
medicines. (88% of all responses were positive.) 
S262  For which of these do your pharmacies have responsibility? (applies to all medicines, including 
investigational medicines) 
S27  Which of these statements are true in your hospital? 
S272  Were pharmacists involved in producing this policy? (71% of all responses were positive.) 
Section 5: Patient Safety and Quality Assurance 
S52  Our hospital has appropriate strategies to detect errors and identify priorities for improvement in 
medicines use processes. (82% of all responses were positive.) 
S522  Were pharmacists involved in approving these procedures? (80% of all responses were positive.) 
S524  In the past three years have you undertaken an audit to identify priorities for improvement in medicines use 
processes? (58% of all responses were positive.) 
 S526  What have you done with the results? 
S53  Does your hospital have a quality assessment programme? (69% of all responses were positive.) 
S532 Is this quality assessment programme internal or external? 
S533  Our hospital acts on these reports to improve the quality and safety of our medicines use processes 
(96% of all responses were positive.) 
S535  For which parts of your service do you use the quality assessment programme? 
S54  The pharmacists in our hospital report adverse drug reactions. (65% of all responses were positive.) 
S543  Our hospital has a process for reporting adverse drug reactions and the staff report these regularly (67% of all 
responses were positive.) 
S545  The pharmacists in our hospital report medication errors. (62% of all responses were positive.) 
S547  Approximately how many medication errors (e.g. were reported by each of your pharmacists (on average) 
  S548  What have you done with the results of these medication error reports? 
S55  The pharmacists in our hospital use evidence-based approaches to reduce the risk of medication errors. 
(78% of all responses were positive.) 
S552  Our hospital pharmacy uses computerised decision support to reduce the risk of medication errors. 
(47% of all responses were positive.) 
S554  Our hospital pharmacy uses computerised decision support in: 
S56  Our hospital has appropriate procedures in place to identify high-risk medicines and minimise the risks 
from their use in the following areas. (88% of all responses were positive.) 
S57  The medicines administration process in our hospital ensures that transcription steps between 
the original prescription and the medicines administration record are eliminated. (70% of all 
   S58  Our patient’s health records accurately record all allergies and other relevant medicine-related information. 
(89% of all responses were positive.) 
S582 Who audits the information held in patient records/medication charts? 
S583  Have there been incidents resulting in patient harm that may have been prevented if the 
pharmacist had been able to access the patient records/medication charts? (63% of all responses were 
i i ) 
 
S59  The pharmacists in our hospital ensure that the information needed for safe medicines use is accessible at 
the point of care. (82% of all responses were positive.) 
S593  Have there been incidents resulting in patient harm that may have been prevented if the information 
provided at the point of care had been improved? (70% of all responses were positive.) 
S510  Medicines in our hospital are packaged and labelled to assure they are safely optimised for 
administration. (85% of all responses were positive.) 
S5103  Hospital pharmacists are involved in processes of secure stocking and dispensing of drugs on wards, 
including a policy for LASA drugs and regular inspections (75% of all responses were positive.) 
S511  Which best describes the traceability of medicines dispensed by our pharmacy? (96% of all responses were 
positive.) 
Section 6: Education and Research 
S62  The pharmacists in our hospital are able to demonstrate their competence to perform their roles. (82% of all 
responses were positive.) 
S621  How do the pharmacists in your hospital demonstrate their competence? 
S63 P h a r m a c i s t s  in our hospital are able to engage in relevant educational opportunities. (90% of responses 
were positive.) 
S632 What educational opportunities are available to your pharmacists? 
S64  The pharmacists in our hospital routinely publish hospital pharmacy practice research. (32% of all 
responses were positive.) 
S641  How many external presentations/papers/posters were submitted last year by your pharmacy? 
S642  How often are internal presentations given by your pharmacy? 
S644  Have you or your pharmacists engaged in development of local/national guidelines? (57% of 
all responses were positive.) 
 Table 2: Questions of 2015 EAHP Statements Survey 
The five questions which received the least positive responses were identified [Table 3], and 
are subject to a more in-depth analysis in this article. These five questions are related to four 
respective Statements: 6.4; 2.5; 5.5; 5.2. 
 
Question Mean* 
S6.4 The pharmacists in our hospital routinely publish hospital pharmacy practice 
 
32% 
S2.5.2 Have you had reason to contact the medicines authority in your country 
because of medicines shortages? 
40% 
S5.5.2 
Our hospital pharmacy uses computerised decision support to reduce the 
risk of medication errors 
47% 
S6.4.4 Have you or your pharmacists engaged in development of local/national 
 
57% 
S5.2.4 In the past three years have you undertaken an audit to identify priorities for 
improvement in medicines use processes? 
58% 
Table 3: Five questions with lowest mean percentage of positive responses across countries 
Questions related to EAHP Statement 6.4: Hospital pharmacists should actively engage in 
and publish research, particularly on hospital pharmacy practice. Research methods should 
be part of undergraduate and postgraduate training programmes for hospital pharmacists. 
The question with the lowest overall percentage of positive responses was S6.4. Figure 5 
shows the breakdown of responses to S6.4 in participating countries. 
 
The graph shows only five countries where 50% or more of hospital pharmacies report that 
their hospital pharmacists routinely publish; the Netherlands, Spain, Italy, Norway plus 
Latvia, which had only one response per country. The majority of countries oscillate around 
30 %, although for some countries this is even smaller, around 10% (Czech Republic, 
Slovakia, Sweden). 
 
The authors then sought the most important barriers to being able to publish more often. 
The responders named insufficient capacity as the most frequent barrier (51%, n=484) 
together with limited capability (19%, n=178) and publication activities not being the 
hospital managers’ priority (16%, n=149) (Fig 6). 
 
Question 6.4.4 was also related to publication activities, but was specifically focused on 
involvement of hospital pharmacists in development of guidelines on local and/or national 
level. As apparent from (Fig 7) the overall involvement in guidelines development is 
significantly higher than publishing the research results, being most frequent in Luxembourg, 
Denmark, the UK, the Netherlands and Ireland. The reasons preventing higher involvement 
stay very similar. The responders who gave a negative response identified the lack of 
capacity as the most frequent barrier (42%, n=177), followed by insufficient capability (19%, 
n=78). From the 'Other' category, the most common theme is that pharmacists are not 
valued, or invited to the process (7 comments). This is in agreement with data from last 
year’s survey, where many pharmacists indicated they do not work in multidisciplinary 
teams, and often feel pharmacists are not valued as other medical personnel. 
 
Question related to Statement 2.5: Each hospital pharmacy should have contingency plans 
for shortages of medicines that it procures. 
 
This Statement is clearly linked to the medicines shortages. Shortages are a persisting 
problem of current healthcare systems.[5] 60% of responders indicated that that they had a 
reason to contact their medicines authority because of shortages. Figure 8 shows that most 
countries have contacted their medicines authority regarding medicine shortages. 100% of 
participants answered ‘Yes’ in Estonia, Iceland and Luxembourg, although these countries 
also had a small amount of total responses.  
 
The participants who answered ‘Yes’ were asked what specific reason they had for 
contacting the medicines authority. The three listed choices ‘To inform them of a drug 
shortage’, ‘To ask them about the details of reasons’ and ‘To enquire on likely timeframe of 
shortage’ were reported with similar frequencies (33%, 31% and 31% respectively, n=849) 
and upon further investigation it was revealed that 123 of the respondents answering this 
question selected all 3 options, implying the pharmacists had been trying to get as much 
information as possible from their medicines authority. The majority of the 44 ‘Other’ 
comments were regarding acquiring alternate medicines, alternate suppliers or approval to 
use imported drugs. 
  
Participants were then asked if the pharmacies in their hospital had contingency plans for 
medication shortages (Question S25). The mean response for countries was 67% positive, 
slightly lower than last year’s result of 70%. The range of responses between countries was 
very high for this question; some reported over 90% positive responses, and others less than 
10% (Fig 9). 
 
The responders who provided a negative response to Question S25 were asked what are the 
barriers to making contingency plans for medication shortages. The most frequent response 
was lack of capacity (106 responses, 31%), as seen in Figure 10. Not considered to be a 
priority by my managers had 69 responses (21%), with the remaining options receiving a 
similar amount. A common theme from the ‘Other’ comments suggest hospitals treat each 
shortage individually, and reactively, as one plan does not fit all situations (13 comments 
under this theme). 7 comments suggest they do not find it necessary to do so. 
 
 
Question S5.5.2 was related to EAHP Statement 5.5: Hospital pharmacists should help to 
decrease the risk of medication errors by disseminating evidence based approaches to error 
reduction including computerised decision support. 
 
When asked if their hospital pharmacy uses computerised decision support to reduce the 
risk of medication errors, Figure 11 shows the response was mixed. Although some countries 
indicate they do this activity, the results show the majority of countries (20) have less than 
half of respondents using computerised decision support to reduce the risk of medication 
errors. 
 
Participants who gave a positive response to the question were asked a follow up question to 
see what areas of pharmacy they use computerised decision support in. The most frequently 
given response is ‘clinical pharmacy services’ (262 total responses, 38%), and this is also the 
main reason given by most individual countries. The remaining options have also been 
selected relatively frequently; cytotoxics (168 total responses, 24%), compounding (128 total 
responses, 19%) and parenteral nutrition/aseptic compounding (107 total responses, 16%). 
Participants who gave a negative response when asked if their hospital pharmacy uses 
computerised decision support were asked to identify the barriers that were preventing this. 
The biggest barriers to implementing computerised decision support are limited capacity 
(166 total, 30%) and that it is not considered a priority by the respondent's managers (147 
total, 27%). Very few people have said they don’t consider it a priority (17 total, 3%), 
indicating this is something a lot of participants may want to be implemented. 
 
The most common response from the 'Other' category was the hospital is currently in the 
process of setting up such a system (21 comments). There are 19 comments saying they do 
not have sufficient IT support or capability to setup or maintain a system. The lack of finance 
to setup a system was also given (8 comments). There were 7 comments saying the hospital 
has a similar system set up, but it is the clinicians that use it, and not the hospital 
pharmacists (7 comments). 
 
Question S5.2.4 was related to Statement 5.2: Hospital pharmacists should ensure the 
development of appropriate quality assurance strategies for medicines use processes to 
detect errors and identify priorities for improvement. 
 
When asked if an audit had been undertaken in the last three years to identify priorities in 
medicines use processes, the mean percentage of positive responses for a country was 58%.  
Figure 12 shows the results broken down by country, which shows over 90% of respondents 
from France, Luxembourg and the Netherlands report having conducted an audit in the last 
3 years. Most other countries show a much smaller proportion of positive responses. 
 
Participants who said they had conducted an audit within the last three years were then 
asked what they did with the results (multiple options allowed). The most common actions 
were writing a report for the hospital board (248 responses) and using the results for 
feedback to their team (233 responses), to inform an education program for pharmacy staff 
and to revise a hospital policy (207 responses). 
 
The participants who indicated that they have not conducted an audit to identify priorities in 
medicines use processes in the last 3 years were asked what is preventing this from 
happening. The most frequent barrier listed was a lack of capacity (147 comments, 40%), 
followed by ‘not considered to be a priority by my managers’ (98 comments, 27%). Only 19 
people (5%) selected ‘not considered to be a priority by me’ as an option. 
 
Discussion 
The 2015 EAHP Statements survey was the first survey of the new 2-year cycle of EAHP 
survey related to European Statements of hospital pharmacy. This Survey was related to 3 of 
6 Sections of Statements and in addition to collecting the basic statistical data about the 
current level of implementation of the Statements, it was also intended to identify the most 
important barriers to and drivers of implementation. 
 
There are several limitations to this study. The first and most important limitation was that 
the number of responses from some member countries was very small, not allowing a 
precise statistical evaluation on country level.  The reason for this is that some countries 
have a much smaller population and therefore have a much smaller number of hospitals. 
The second limitation was the necessity to find a balance between the length of the 
questionnaire (and the workload for responders) and level of detail sought in identification 
of the main implementation barriers. 
 
Despite these limitations, the survey results provide an up to date picture about the current 
state of our profession in Europe in relation to the Statements. The most challenging 
Statements in sections 2,5 and 6 for implementation remain the publication of the research 
activities, creating contingency plans for medicines shortages, implementing and using 
computer-supported decision tools, involvement in developing local and national guidelines 
and policies, and identification priorities for improvement in medicines use processes.  
 
The main barrier identified is insufficient capacity to undertake the services, and the results 
of this survey confirm the finding from the EAHP Baseline survey. The numbers of hospital 
pharmacists and pharmacy technicians remain quite low in many European countries. 
Almost half of hospitals in this survey had over 500 beds, but 80 % of hospitals had up to 10 
pharmacists. While significant improvement in staffing level cannot be a short term goal, 
EAHP will provide education on the development of business cases and the self-assessment 
tool will enable head pharmacists to have real time information to discuss with hospital and 
health system managers. The answer ‘not being considered priority by my managers’ was 
also quite often mentioned and here the authors see even bigger opportunities in speeding 
up the implementation and raising awareness about statements and their impact on 
patients and healthcare systems. The level of awareness, implementation readiness and 
willingness was also measured in this survey; and will be a subject of an additional article. 
 
The next survey in autumn 2016 will be focused on Sections 1, 3 and 4, followed by another 
survey in 2017 which will revisit the sections described in this paper. The authors will then 
be able to compare the results and track any progress. 
 
Conclusion 
The main objective of the 2015 EAHP Statements survey was to provide an assessment of 
the level of implementation with Sections 2, 4 and 5 of the Statements throughout European 
countries and to identify the main barriers to and drivers of implementation. This enables 
the EAHP to prioritise efforts in our implementation activities. This objective has been 
reached, thanks to enormous effort of national coordinators and all our members who had 
responded to the survey. The data will now be used to inform the EAHP Statements 
implementation project as well as other major projects of EAHP. 
 
What is already known on this subject 
The 2014/15 EAHP Baseline survey, as the first survey of new EAHP line, brought general 
knowledge about level of Statements implementation. 
What this paper adds 
This paper deepens knowledge about the level of implementation in Statements section 2, 5 
and 6 together with identification of the main barriers in implementation. 
The most challenging Statements for implementation in hospital pharmacies are: 
• the publication of the research activities,  
• creating contingency plans for medicines shortages,  
• implementing and using computer-supported decision tools,  
• involvement in developing local and national guidelines and policies,  
• identification priorities for improvement in medicines use processes. 
The most important barrier in implementation is insufficient capacity and different priorities 
of hospital and health-system managers. 
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